Cepheid Inks First in Series of Agreements to Buy Down Price of Xpert TB Test
August 09, 2012
Cepheid Inks First in Series of Agreements to Buy Down Price of Xpert TB Test
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
December 6, 2012 / PCR Insider - Unitaid Provides $30M to Reduce Cost, Increase Uptake of Cepheid TB Test in Developing World
June 14, 2012 / PCR Insider - Unitaid Provides $30M to Lower Cost of Cepheid TB Test in Developing World
June 14, 2012 / GenomeWeb Daily News - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Johns Hopkins-Led Team Shows Potential of Multiplex Allele-Specific PCR to Detect MDR-TB
August 2, 2012 / PCR Insider